Hypertrophic cardiomyopathy.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Archives of Disease in Childhood

• Publication date

  1994-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/adc.71.6.488PMID 7726605PMCID PMC1030082
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A disease locus for familial hypertrophic cardiomyopathy maps to chromosome 1q3

  1993cited by this paper
• Cardiologic Abnormalities in Noonan Syndrome: Phenotypic Diagnosis and Echocardiographic Assessment of 118 Patients

  1993cited by this paper
• Prenatal diagnosis of Pompe's disease (type ii glycogenosis) in chorionic villus biopsy using maltose as a substrate

  1992cited by this paper
• Diseases of the mitochondrial DNA.

  1992cited by this paper
• Differences in Clinical Expression of Hypertrophic Cardiomyopathy Associated With Two Distinct Mutations in the β‐Myosin Heavy Chain Gene: A 908Leu→Val Mutation and a 403Arg→gGln Mutation

  1992cited by this paper
• Evidence of Genetic Heterogeneity in Five Kindreds With Familial Hypertrophic Cardiomyopathy

  1992cited by this paper
• Prognostic Determinants in Hypertrophic Cardiomyopathy: Prospective Evaluation of a Therapeutic Strategy Based on Clinical, Holter, Hemodynamic, and Electrophysiological Findings

  1992cited by this paper
• Myocardial disarray in Noonan syndrome

  1992cited by this paper
• Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy.

  1992cited by this paper
• Abnormal Vascular Responses to Supine Exercise in Hypertrophic Cardiomyopathy

  1991cited by this paper
• Sudden death during empiric amiodarone therapy in symptomatic hypertrophic cardiomyopathy.

  1991cited by this paper
• A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation.

  1990cited by this paper
• Impaired Skin Fibroblast Carnitine Uptake in Primary Systemic Carnitine Deficiency Manifested by Childhood Carnitine-Responsive Cardiomyopathy

  1990cited by this paper
• Hypertrophic cardiomyopathy without hypertrophy: two families with myocardial disarray in the absence of increased myocardial mass.

  1990cited by this paper
• Sudden death in hypertrophic cardiomyopathy. Assessment of patients at high risk.

  1989cited by this paper
• Mapping a gene for familial hypertrophic cardiomyopathy to chromosome 14q1.

  1989cited by this paper
• Mitochondrial myopathies.

  1989cited by this paper
• Arrhythmia and prognosis in infants, children and adolescents with hypertrophic cardiomyopathy.

  1988cited by this paper
• Inheritance of hypertrophic cardiomyopathy: a cross sectional and M mode echocardiographic study of 50 families.

  1987cited by this paper
• Development and progression of left ventricular hypertrophy in children with hypertrophic cardiomyopathy.

  1986cited by this paper
• Mitochondrial myopathies

  1985cited by this paper
• Noonan syndrome: the changing phenotype.

  1985cited by this paper
• Hypertrophic cardiomyopathy: an important cause of sudden death.

  1984cited by this paper
• The natural history of hypertrophic cardiomyopathy.

  1981cited by this paper
• Characterization of the Cardiomyopathy in Infants of Diabetic Mothers

  1980cited by this paper
• Quantitative Analysis of Cardiac Muscle Cell Disorganization in the Ventricular Septum of Patients with Hypertrophic Cardiomyopathy

  1979cited by this paper
• Further characterization of the hypertrophic cardiomyopathy of infants of diabetic mothers

  1978cited by this paper
• Prenatal diagnosis of Pompe's disease.

  1971cited by this paper

• Targeting the Sarcomere: Myosin Inhibitors as the Revolutionary Game Changer in Hypertrophic Cardiomyopathy

  2026cites this paper
• Exploring the Potential Mechanism of Polyethylene Terephthalate Associated Cardiotoxicity through Network Toxicology and Molecular Docking.

  2026cites this paper
• AI Applications in Electrocardiography for Ischemic and Structural Heart Disease: A Review of the Current State

  2026cites this paper
• Prevalence of arrhythmias in a population of athletes ineligible for competitive sports activity

  2026cites this paper
• Hypertrophic Obstructive Cardiomyopathy During Pregnancy: A Report of Two Cases.

  2026cites this paper
• What Does Improvement Mean?: Interpreting Progress and Evidence in Hypertrophic Cardiomyopathy.

  2026cites this paper
• Case Report: Genomic and clinical insights into MYBPC3-related hypertrophic cardiomyopathy in Ecuadorian patients: implications for sudden cardiac death risk

  2026influential citation
• Genetic testing in cardiomyopathies: do we need to redefine the UK national testing criteria?

  2026cites this paper
• Cost-effectiveness analysis of mavacamten for obstructive hypertrophic cardiomyopathy: a perspective from the Chinese healthcare system

  2026cites this paper
• Bucking Conventional Wisdom: The Experience of Cardiac Myosin Inhibitors in Hypertrophic Cardiomyopathy.

  2026cites this paper
• Novel off-pump ventricular septal myectomy for obstructive hypertrophic cardiomyopathy: A paradigm shift in surgical management

  2026cites this paper
• Anestesia-reanimación en cirugía de la hipófisis

  2025cites this paper
• Endothelial-specific genes TMTC1, RPS6KA2, and F8 are downregulated in hypertrophic cardiomyopathy

  2025influential citation
• Automated Deep Learning Based Cardiac Quantification in Hypertrophic Cardiomyopathy: A Comparative Study with Manual Segmentation

  2025cites this paper
• The Utility of Genome-Wide Association Studies in Inherited Arrhythmias and Cardiomyopathies

  2025cites this paper
• Congestive heart failure after enterotomy in a cat with asymptomatic transient myocardial thickening

  2025cites this paper
• Hypertrophic Cardiomyopathy Mimicking a Primary Cardiac Tumor: Case Report and Review of Molecular Genetic Findings.

  2025cites this paper
• PathCo-LatticE: Pathology-Constrained Lattice-Of Experts Framework for Fully-supervised Few-Shot Cardiac MRI Segmentation

  2025cites this paper
• Rethinking Childhood-Onset Hypertrophic Cardiomyopathy: A Review of Molecular Mechanisms and Unique Therapy Considerations

  2025influential citation
• Myocardial disarray drives metabolic inefficiency in human cardiomyocytes

  2025cites this paper
• Computational discovery of novel SIRT4 inhibitors for cardiac hypertrophy treatment.

  2025cites this paper
• Echocardiographic Features of Cardiomyopathies: A Comprehensive Review

  2025cites this paper
• Conformational State of Myosin’s Disordered Loop 2 Structure Mediates Actomyosin Association During Crossbridge Formation

  2025cites this paper
• Transcriptional and functional effects of mavacamten in multiple porcine and human models with hypertrophic cardiomyopathy

  2025cites this paper
• Systemic barriers and opportunities for equity in early implementation of genetic testing and counseling for cardiomyopathies in Tanzania

  2025cites this paper
• A Comparative Analysis of Machine Learning Approaches to classify Genomic Variants causing Inherited Cardiovascular Disorders

  2025cites this paper
• Hypertrophic cardiomyopathy in identical twins: a case report with mismatch between genotype and phenotype

  2025cites this paper
• Challenges in the Diagnosis and Management of Hypertrophic Cardiomyopathy and the Promise of Artificial Intelligence.

  2025cites this paper
• Mendelian Randomization Study Reveals Causal Pathways for Hypertrophic Cardiomyopathy, Cardiovascular Proteins, and Atrial Fibrillation.

  2025cites this paper
• Anesthetic Considerations and Management of Spine Surgery Performed Under Neuraxial Anesthesia

  2025cites this paper
• Identification of hypertrophic cardiomyopathy on electrocardiographic images with deep learning

  2025cites this paper
• Genetic and Gender Influences on Hypertrophic Cardiomyopathy: A Comprehensive Population-based Study of Clinical Outcomes and Implications

  2025cites this paper
• New Solution for Segmental Assessment of Left Ventricular Wall Thickness, Using Anatomically Accurate and Highly Reproducible Automated Cardiac MRI Software

  2025cites this paper
• Current management of hypertrophic cardiomyopathy

  2025cites this paper
• Protective effects of flavonoids against silver nanoparticles-induced toxicity

  2025cites this paper
• The incremental role of late gadolinium enhancement in risk stratifying high risk patients with hypertrophic cardiomyopathy.

  2025cites this paper
• Age and Sex Differences in the Risk of Sudden Cardiac Death in Patients with Hypertrophic Cardiomyopathy: A Multi-Centre Cohort Study

  2025influential citation
• Deteriorated biomechanical properties of human hypertrophied septum in response to cardiomyocyte enlargement, overexpressed collagen, and disarrayed microstructures

  2025cites this paper
• Qualitative analysis of experiences, burdens, and needs among patients with hypertrophic cardiomyopathy in Japan

  2025cites this paper
• Convolutional Neural Network Fused With Recurrent Network for ECG‐Based Detection of Hypertrophic Cardiomyopathy

  2025cites this paper
• Left ventricular septal convexity in differentiating hypertrophic cardiomyopathy from hypertensive heart disease – a cardiac magnetic resonance study

  2025cites this paper
• Nobiletin protected against hypertrophic cardiomyopathy via targeting PPARα

  2025cites this paper
• Knowledge, attitude, and practice toward hypertrophic cardiomyopathy of patients with primary hypertension: a cross-sectional study

  2025cites this paper
• Clinico-morphological evaluation of Hypertrophic Cardiomyopathy patients in cardiac MRI with an evaluation of prognostic parameters in tertiary cardiac centre

  2025cites this paper
• Integration of multi-omics and machine learning strategies identifies immune related candidate biomarkers in inflammation-associated hypertrophic cardiomyopathy

  2025cites this paper
• The Neuro-Immune Axis in Cardiomyopathy: Molecular Mechanisms, Clinical Phenotypes, and Therapeutic Frontiers

  2025cites this paper
• Toxicological profile of Acovenoside A as an active pharmaceutical ingredient - prediction of missing key toxicological endpoints using in silico toxicology methodology.

  2025cites this paper
• Beta blockers and hypertrophic obstructive cardiomyopathy: a systematic review and meta-analysis

  2025cites this paper
• Rescue Mitral Clip Therapy in Hypertrophic Obstructive Cardiomyopathy with Severe Mitral Regurgitation and Combined Shock.

  2025cites this paper
• Integrating metabolomics and network pharmacology to investigate YangxinDingji Capsule alleviates myocardial injury in tachyarrhythmia rat.

  2025cites this paper
• Model-Based Economic Evaluation of the First-in-Class Myosin Inhibitor Mavacamten Versus Care as Usual in Obstructive Hypertrophic Cardiomyopathy Patients from a Dutch Societal Perspective

  2025cites this paper
• In vitro approaches to mimic cardiac mechanical load dynamics for enhancing maturation and disease modelling

  2025cites this paper
• Dynamic left ventricular outflow tract obstruction in critical illness: etiology-driven management and the role of bedside transthoracic echocardiography

  2025cites this paper
• A machine Learning-Based risk stratification using CMR volumetric and strain parameters in patients with hypertrophic cardiomyopathy

  2025cites this paper
• Integrated Multi-omics Analysis of Hub Genes and miRNA Interactions in Hypertrophic Cardiomyopathy

  2025cites this paper
• Direction-dependent contributions of cardiac myofilament networks to myocardial passive stiffness reveal a major disparity for titin

  2025cites this paper
• Arrhythmias and Sudden Death: What is New in Hypertrophic Cardiomyopathy?

  2025influential citation
• Causes of sudden cardiac death in professional athletes

  2025cites this paper
• Comprehensive plasma metabolomics profiling develops diagnostic biomarkers of obstructive hypertrophic cardiomyopathy

  2025cites this paper
• Echocardiography and Heart Failure: An Echocardiographic Decision Aid for the Diagnosis and Management of Cardiomyopathies

  2025influential citation
• H2FPEF and HFA‐PEFF scores for heart failure risk stratification in hypertrophic cardiomyopathy patients

  2025cites this paper
• The Efficacy and Safety of Cardiac Myosin Inhibitors Versus Placebo in Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials.

  2025cites this paper
• How Would We Treat Our Own Left Ventricular Outflow Tract Obstruction in Transcatheter Mitral Valve Replacement?

  2025cites this paper
• Treatment patterns, outcomes and healthcare resource utilization of obstructive hypertrophic cardiomyopathy in England

  2025cites this paper
• Developmental and Evolutionary Heart Adaptations Through Structure–Function Relationships

  2025cites this paper
• Molecular imaging in hypertrophic cardiomyopathy: an exploratory study with 2-[18F]FDG and [13N]NH3

  2025cites this paper
• Exercise and Hypertrophic Cardiomyopathy: Risks, Benefits, and Safety - A Systematic Review and Meta-analysis

  2025cites this paper
• Complementary classification of hypertrophic cardiomyopathy using unsupervised cluster analysis on left ventricular function

  2025cites this paper
• Lysine crotonylation in disease: mechanisms, biological functions and therapeutic targets

  2025cites this paper
• A Multidimensional Approach to Understanding Genetic Diversity, Risk Stratification, and Personalized Interventions in Pediatric Hypertrophic Cardiomyopathy.

  2025cites this paper
• Understanding inherited cardiomyopathies: clinical aspects and genetic determinants

  2025cites this paper
• Regulation of different types of diseases by lncRNA ADAMTS9-AS1

  2025cites this paper
• Advances in the management of obstructive hypertrophic cardiomyopathy: The role of mavacamten

  2025cites this paper
• Protein interactions, network pharmacology, and machine learning work together to predict genes linked to mitochondrial dysfunction in hypertrophic cardiomyopathy

  2025cites this paper
• GEO combined with quantitative protein trait loci identify causative proteins in hypertrophic cardiomyopathy

  2025cites this paper
• Assessing Dental Care Utilization Status and Caregiver Satisfaction with Dental Treatment for Pediatric Patients with Rare Diseases

  2025cites this paper
• Hypertrophic cardiomyopathy in the trauma patient: A case report and review of the literature

  2025cites this paper
• A Narrative Review of Current and Investigational Therapies in Hypertrophic Cardiomyopathy

  2025cites this paper
• Application of 2‐Dimensional Speckle Tracking Technology for Trastuzumab‐Induced Cardiotoxicity in a New Mouse Model

  2025cites this paper
• Back to normal: super-response to mavacamten in a patient with obstructive hypertrophic cardiomyopathy

  2025cites this paper
• Beyond conventional therapy: NOX4 as a promising target in cardiomyopathy

  2025cites this paper
• Hypertrophic Cardiomyopathy in a Fetus: A Rare Presentation Case Report

  2025cites this paper
• Direct oral anticoagulants versus vitamin K antagonists in concurrent hypertrophic cardiomyopathy and atrial fibrillation: a meta-analysis

  2025cites this paper
• Investigating the role of long non-coding RNA in hypertrophic cardiomyopathy

  2025cites this paper
• Role of Dyadic Proteins in Proper Heart Function and Disease

  2025cites this paper
• Asymptomatic Apical Hypertrophic Cardiomyopathy Uncovered During Routine Preoperative Evaluation

  2025cites this paper
• Suspected Familial Hypertrophic Cardiomyopathy in a 13-Year-Old Male From an Underserved Region of the Dominican Republic: A Case Report

  2025influential citation
• Echocardiographic Examination of 16 Eastern Grey Kangaroos (Macropus giganteus) and One Red Kangaroo (Osphranter rufus)

  2025influential citation
• Cardiopulmonary Exercise Testing in Hypertrophic Cardiomyopathy: Refining a Proven Tool for Better Risk Prognostication

  2025cites this paper
• HYPERTROPHIC CARDIOMYOPATHY IN ATHLETES - A LITERATURE REVIEW

  2025influential citation
• Development of an Arrhythmogenic Cardiomyopathy Model Using CRISPR-Cas9 and Homology-Directed Repair

  2025cites this paper
• Cardiac Myosin Inhibitors in Hypertrophic Cardiomyopathy: From Sarcomere to Clinic

  2025influential citation
• Hypertrophic cardiomyopathy mutations Y115H and E497D disrupt the folded-back state of human β-cardiac myosin allosterically

  2025cites this paper
• Significance of the Monitoring Right Ventricular Echocardiographic Parameters in Patients with Hypertrophic Cardiomyopathy Undergoing Alcohol Septal Ablation—A Single-Center Experience

  2025cites this paper
• AAV9-mediated MYBPC3 gene therapy with optimized expression cassette enhances cardiac function and survival in MYBPC3 cardiomyopathy models

  2025cites this paper
• Evaluation of sudden cardiac death in hypertrophic cardiomyopathy

  2025cites this paper
• Integrative multi-omics identifies MEIS3 as a diagnostic biomarker and immune modulator in hypertrophic cardiomyopathy

  2025cites this paper
• A novel variant in MYBPC3 causes hypertrophic cardiomyopathy by haploinsufficiency

  2025cites this paper
• Desenmascarando el gradiente oculto: el papel de la ecocardiografía de esfuerzo en la miocardiopatía hipertrófica

  2025cites this paper
• O Complexo Quebra-Cabeça do Fenótipo Hipertrófico: Uma Abordagem Prática para o Clínico

  2025cites this paper